Nasal spray intended for Covid prevention in the future: SaNOtize CEO
SaNOtize CEO Gilly Regev says the company is conducting a large prevention trial with a goal that everyone can use the nasal spray in the future.
SaNOtize CEO Gilly Regev says the company is conducting a large prevention trial with a goal that everyone can use the nasal spray in the future.
Multiple variants and waves of Covid-19 have shown vaccines alone won’t be enough to control the virus, underlining the need for other treatments against it.
Pfizer's Paxlovid shows 90% efficacy, while much hyped MSD's Molnupiravir is less effective.